Content Type

Topic Categories

Date Range

Journalism Grants

Funding For:

Autoimmune Drugs and Rising Adverse Events


Recipient:

The Milwaukee Journal Sentinel, MedPage Today & USA Today Network

Grant Period:

Jan 01, 2019 - Dec 31, 2019

AMOUNT:

$40,000.00

Summary of the Project:

A growing number of Americans are taking immunosuppressant drugs. This investigation seeks to understand why and examines different issues with the drugs, their approval and usage.

About the Grantee:

The Milwaukee Journal Sentinel, which is part of the USA Today Network, and MedPage Today, an online medical news organization, have teamed up to produce dozens of high-impact, national award-winning investigative medical projects. In 2016, after the Journal Sentinel was purchased by Gannett, stories from the partnership also began running in USA Today and other publications in the USA Today Network, which includes 109 newspapers and affiliated websites.

Related Grantee Work

August 07, 2019

What's behind the surge of prescriptions for risky, expensive medications? Millions from drugmakers.

The third piece in a series on autoimmune drugs, this story investigated how spending by pharmaceutical companies promotes prescribing of their drugs through marketing to doctors and direct-to-consumer advertising, even when there may be more clinically appropriate or cost-effective options.

Learn More

Author: John Fauber

July 18, 2019

A drug's most dangerous side effects often aren't discovered until it's on the market

The second piece in a series on autoimmune drugs, this story shared how patients weigh the risks of side effects with the reward of a heightened quality of life due to relief from the symptoms of autoimmune diseases.

Learn More

Author: John Fauber

May 31, 2019

Biologics to treat arthritis have flooded the market. They're also linked to 34,000 deaths

Learn More

Author: John Fauber and Kevin Crowe

May 30, 2019

Biologic medications for arthritis and psoriasis have flooded the market — and been linked to 34,000 deaths

Part of a series investigating adverse events from drugs designed to treat autoimmune diseases, this story examined how biologic drugs can leave patients more susceptible to infections and side effects, sometimes with fatal results.

Learn More

Author: John Fauber and Kevin Crowe